US20180256699A1
University of Texas System
The present disclosure describes immunogenic portions of Bordetella adenylate cyclase toxin (ACT), and neutralizing antibodies specific for such polypeptides. The antibodies can be used for diagnosis and anti- Bordetella therapies. Further provided are vaccine compositions including recombinant …